Analytical Laboratories, Inc provides a full service, certified environmental laboratory capable of performing a variety of scientific services and testing.

Analytical Laboratories, Inc

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Metric
Company Name	Analytical Laboratories, Inc	Revvity, Inc.
Symbol		RVTY
MSH ID	COM:ANALYTICALLABSINC	COM:PERKINELMER
Market	PRIVATE	STOCKS
Sector	Commercial & Professional Services	Healthcare
Industry	Laboratory Services	Medical - Diagnostics & Research
Country	US	US
Stage
Employee Count		11K
Website	analyticallabsinc.com	perkinelmer.com
LinkedIn
Founders

Metric
Market Cap		13.16B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		2.75B
Revenue (LTM)
Revenue (NTM)
Gross Profit		1.17B
EBITDA		732.33M
Operating Income		300.56M
Net Income		179.50M
EPS		1.44
Diluted EPS		1.44
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.53
Operating Profit Margin		0.11
EBITDA Margin		0.27
Net Profit Margin		0.07
Return on Equity		0.02
Return on Assets		0.01
Return on Capital Employed		0.02

ANAL

COM:ANALYTICALLABSINC

Analytical Laboratories, Inc

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		72.51
P/B Ratio		1.67
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		5.79
EV Multiple		17.84

Metric
Days Sales Outstanding		84.15
Days Payables Outstanding		57.12
Days Inventory Outstanding		120.14
Operating Cycle		204.11
Cash Conversion Cycle		146.83
Asset Turnover		0.20

Metric
Operating Cash Flow		91.27M
Free Cash Flow		9.90M
Cash Flow to Debt		0.12
Operating Cash Flow/Sales		0.17
Free Cash Flow Yield		-0.00

Metric
Cash & Equivalents		914.37M
Accounts Receivable		-9.00M
Inventory		428.06M
Goodwill		6.53B
Debt to Capitalization		0.33
Debt to Assets		0.30
Current Ratio		2.01
Quick Ratio		1.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue		0.08
SG&A to Revenue